Home > News > NanoNovus: May 8
May 8th, 2006
NanoNovus: May 8
Jack Uldrich: This article from the Miami Herald provides a good overview of nanotechnology’s ability (and limitations) to detect cancer at an early stage. On the positive side, nanotechnology is leading to the development and creation of new diagnostic technologies that can detect unique “biomarkers”–specific proteins that show up when a cancer is present.
On the down side, these biomarkers are not always either sensitive or specific to a single disease. This suggests that even if new diagnostic technologies are developed, they might not do that much good.
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014
The Pocket Project will develop a low-cost and accurate point-of-care test to diagnose Tuberculosis: ICN2 holds a follow-up meeting of the Project on September 18th - 19th September 18th, 2014
New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014
Recruiting bacteria to be technology innovation partners: September 17th, 2014